Search research articles
Contact Us
Filters
Showing results (41-50 of 339) with videos related to
Page
of 34
Sort By:
Nature Reviews. Clinical Oncology
|
May 26, 2018
Next-generation sequencing for measuring minimal residual disease in AML
Roland B Walter, Frederick R Appelbaum
Blood
|
July 2, 2011
Indications for and current results with allogeneic hematopoietic cell transplantation in patients with myelofibrosis
H Joachim Deeg, Frederick R Appelbaum
Best Practice & Research. Clinical Haematology
|
March 7, 2006
Hematopoietic cell transplantation in first complete remission versus early relapse
Frederick R Appelbaum, S Frieda Pearce
Expert Review of Hematology
|
October 3, 2013
Risk assessment before allogeneic hematopoietic cell transplantation for older adults with acute myeloid leukemia
Mohamed L Sorror, Frederick R Appelbaum
Clinical Advances in Hematology & Oncology : H&O
|
November 29, 2012
To transplant or not to transplant for adult acute myeloid leukemia: an ever-evolving decision
Aaron T Gerds, Frederick R Appelbaum
Oncology (Williston Park, N.Y.)
|
September 11, 2012
Unfavorable, complex, and monosomal karyotypes: the most challenging forms of acute myeloid leukemia
Johnnie J Orozco, Frederick R Appelbaum
Blood
|
October 13, 2017
Gemtuzumab ozogamicin for acute myeloid leukemia
Frederick R Appelbaum, Irwin D Bernstein
Blood
|
July 8, 2017
CHIPs and engraftment dips
Frederick R Appelbaum, Jerald P Radich
The New England Journal of Medicine
|
December 14, 2016
Cord-Blood Transplantation in Patients with Minimal Residual Disease
Filippo Milano, Frederick R Appelbaum, Colleen Delaney
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 3, 2014
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia
Paresh Vyas, Frederick R Appelbaum, Charles Craddock
Page
of 34
Search research articles
Search
Showing results (41-50 of 339) with videos related to
Sort By:
Page
of 34
Nature Reviews. Clinical Oncology
|
May 26, 2018
Next-generation sequencing for measuring minimal residual disease in AML
Roland B Walter, Frederick R Appelbaum
Blood
|
July 2, 2011
Indications for and current results with allogeneic hematopoietic cell transplantation in patients with myelofibrosis
H Joachim Deeg, Frederick R Appelbaum
Best Practice & Research. Clinical Haematology
|
March 7, 2006
Hematopoietic cell transplantation in first complete remission versus early relapse
Frederick R Appelbaum, S Frieda Pearce
Expert Review of Hematology
|
October 3, 2013
Risk assessment before allogeneic hematopoietic cell transplantation for older adults with acute myeloid leukemia
Mohamed L Sorror, Frederick R Appelbaum
Clinical Advances in Hematology & Oncology : H&O
|
November 29, 2012
To transplant or not to transplant for adult acute myeloid leukemia: an ever-evolving decision
Aaron T Gerds, Frederick R Appelbaum
Oncology (Williston Park, N.Y.)
|
September 11, 2012
Unfavorable, complex, and monosomal karyotypes: the most challenging forms of acute myeloid leukemia
Johnnie J Orozco, Frederick R Appelbaum
Blood
|
October 13, 2017
Gemtuzumab ozogamicin for acute myeloid leukemia
Frederick R Appelbaum, Irwin D Bernstein
Blood
|
July 8, 2017
CHIPs and engraftment dips
Frederick R Appelbaum, Jerald P Radich
The New England Journal of Medicine
|
December 14, 2016
Cord-Blood Transplantation in Patients with Minimal Residual Disease
Filippo Milano, Frederick R Appelbaum, Colleen Delaney
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 3, 2014
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia
Paresh Vyas, Frederick R Appelbaum, Charles Craddock
Page
of 34